首页 > 最新文献

International Journal of Radiology & Radiation Therapy最新文献

英文 中文
Lasers: light in the dental office 激光:牙科诊所里的光
Pub Date : 2020-07-27 DOI: 10.15406/ijrrt.2020.07.00276
R. M, Jayrekha Tadiparthi, Latha Muniswamy, M. Chethan, Karthik D Yadav
Lasers have been largely used in the field of dentistry, they provide a high quality, precision treatment modality with and a great reduction or lack of posttreatment pain, making the patient experience somewhat easier. Lasers play an integral part in treating oral mucosal lesions. Its use is not only limited to oral mucosal lesions alone but also stepping into the field of endodontics and periodontics. Lasers have already established itself in the field of surgery.
激光已广泛应用于牙科领域,它们提供了高质量,精确的治疗方式,并大大减少或缺乏治疗后疼痛,使患者体验更容易。激光在治疗口腔黏膜病变中起着不可或缺的作用。它的应用不仅局限于口腔粘膜病变,而且还进入了牙髓学和牙周学领域。激光已经在外科手术领域站稳了脚跟。
{"title":"Lasers: light in the dental office","authors":"R. M, Jayrekha Tadiparthi, Latha Muniswamy, M. Chethan, Karthik D Yadav","doi":"10.15406/ijrrt.2020.07.00276","DOIUrl":"https://doi.org/10.15406/ijrrt.2020.07.00276","url":null,"abstract":"Lasers have been largely used in the field of dentistry, they provide a high quality, precision treatment modality with and a great reduction or lack of posttreatment pain, making the patient experience somewhat easier. Lasers play an integral part in treating oral mucosal lesions. Its use is not only limited to oral mucosal lesions alone but also stepping into the field of endodontics and periodontics. Lasers have already established itself in the field of surgery.","PeriodicalId":214028,"journal":{"name":"International Journal of Radiology & Radiation Therapy","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121657242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Techniques to verify the correct skin areas for biopsy, treatment, recurrence and in-vivo dosimetry using an A4 plastic sheet as template 使用A4塑料片作为模板验证活检、治疗、复发和体内剂量测定的正确皮肤区域的技术
Pub Date : 2020-07-24 DOI: 10.15406/ijrrt.2020.07.00275
Ben Alcevski, Tiarna Shearer, Yeen Yeong, G. Fogarty
Introduction Radiotherapy (RT) is a precise treatment usually given over multiple sessions with millimetre accuracy to the planned target. Patients undergoing RT require verification of the target area prior each treatment. Imaging with kilovoltage X-rays is usually used to verify the treatment volumes of solid internal tumours, but this process is unsuitable for skin cancers as it cannot visualise skin marks. When biopsying or treating skin cancers, there is a chance that other nearby benign skin structures can be confused with the lesion of concern. Templates using transparent sheets have been used to verify the treatment area. We present a series of cases to demonstrate our skin cancer verification technique using the humble A4 plastic sheet protector. Case series: Case 1 details the use of a plastic sheet template to correctly identify lesions that require biopsy. Cases 2 and 3 describe how templates are used for in-field verification prior to electron and superficial RT treatment, respectively. Case 4 shows how stored templates can be used to quantify recurrence. Conclusion: For skin cancer planning and verification, the A4 plastic sheet protector is easy to use, reproducible, economical and storable. It serves multiple purposes: to delineate areas of biopsy and treatment, to discover whether a recurrence is in-field or not, and to also verify where in vivo dosimetry should be measured.
放射治疗(RT)是一种精确的治疗,通常在多个疗程中以毫米精度给予计划目标。接受放射治疗的患者需要在每次治疗前验证靶区。千伏x射线成像通常用于验证实体内部肿瘤的治疗体积,但该过程不适合皮肤癌,因为它不能看到皮肤痕迹。当进行活组织检查或治疗皮肤癌时,有可能将附近的其他良性皮肤结构与相关病变混淆。使用透明纸的模板已用于验证处理区域。我们提出了一系列的案例,以证明我们的皮肤癌验证技术使用简陋的A4塑料片保护器。病例系列:病例1详细介绍了使用塑料片模板正确识别需要活检的病变。案例2和3分别描述了在电子和表面RT治疗之前如何使用模板进行现场验证。案例4显示了如何使用存储的模板来量化复发。结论:用于皮肤癌的规划和验证,A4塑料片保护膜使用方便、可复制、经济、易保存。它有多种用途:划定活检和治疗的区域,发现复发是否为现场,并验证体内剂量学应该在哪里测量。
{"title":"Techniques to verify the correct skin areas for biopsy, treatment, recurrence and in-vivo dosimetry using an A4 plastic sheet as template","authors":"Ben Alcevski, Tiarna Shearer, Yeen Yeong, G. Fogarty","doi":"10.15406/ijrrt.2020.07.00275","DOIUrl":"https://doi.org/10.15406/ijrrt.2020.07.00275","url":null,"abstract":"Introduction Radiotherapy (RT) is a precise treatment usually given over multiple sessions with millimetre accuracy to the planned target. Patients undergoing RT require verification of the target area prior each treatment. Imaging with kilovoltage X-rays is usually used to verify the treatment volumes of solid internal tumours, but this process is unsuitable for skin cancers as it cannot visualise skin marks. When biopsying or treating skin cancers, there is a chance that other nearby benign skin structures can be confused with the lesion of concern. Templates using transparent sheets have been used to verify the treatment area. We present a series of cases to demonstrate our skin cancer verification technique using the humble A4 plastic sheet protector. Case series: Case 1 details the use of a plastic sheet template to correctly identify lesions that require biopsy. Cases 2 and 3 describe how templates are used for in-field verification prior to electron and superficial RT treatment, respectively. Case 4 shows how stored templates can be used to quantify recurrence. Conclusion: For skin cancer planning and verification, the A4 plastic sheet protector is easy to use, reproducible, economical and storable. It serves multiple purposes: to delineate areas of biopsy and treatment, to discover whether a recurrence is in-field or not, and to also verify where in vivo dosimetry should be measured.","PeriodicalId":214028,"journal":{"name":"International Journal of Radiology & Radiation Therapy","volume":"358 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115942493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Whole brain radiotherapy with partial hair-sparing technique-a feasibility study 全脑放射治疗部分留发技术的可行性研究
Pub Date : 2020-07-20 DOI: 10.15406/ijrrt.2020.07.00274
Narelle Williams, F. Boyle, A. Hong, Hsien Chan, E. Paton, Kerryn Miller, Z. Moutrie, Sinead Mulrennan, Bianca Karle, Gerald B Fobarty
Introduction: Whole brain radiotherapy (WBRT) is a common palliative treatment for brain metastases from solid tumours. Traditionally, it is given with opposed lateral fields causing total alopecia as hair-bearing scalp skin receives the full dose. Volumetric modulated arc therapy (VMAT) can deliver WBRT with a simultaneous integrated boost (SIB) to larger metastases whilst minimising dose to critical structures such as the hippocampus. This feasibility study aimed to test the hypothesis that a reduced dose to the scalp using a VMAT hair-sparing WBRT protocol would spare scalp hair and reduce alopecia at four weeks post treatment without compromising disease control at three months. Methods: The Hair Spare study (01.07 WBRTMel sub-study SS01.13) was an investigator-initiated, prospective feasibility study. A VMAT hair-sparing WBRT protocol was developed to limit the dose to the scalp to 16 Gray (Gy) in 15 fractions. The primary objective was the rate of alopecia at 4 weeks post RT as measured by CTCAE v4 and clinician and patient perception. Quality of life (QoL) was assessed at baseline, one month and three months post treatment with validated instruments including European Organisation for Research and Treatment of Cancer (EORTC) QoL Questionnaire (QLQ-C15-PAL+4) plus four additional questions specifically relating to hair, a visual analogue scale (VAS) to measure the perception of hair loss severity, and the total Chemotherapy-Induced Alopecia Distress Scale (CADS). Results: Nine patients with brain metastases from melanoma (6), breast (2) and lung (1) cancer were enrolled at the Mater Sydney Hospital, Crows Nest, Australia. At 4 weeks, 5 patients were evaluable: 4 reported moderate alopecia (CTCAE v4 Grade 2) and 1 reported mild alopecia (CTCAE v4 Grade 1). All 5 wore wigs or scarves to hide hair loss. Any amount of hair loss impacted QoL. Reduced hair loss compared to complete alopecia, as usually found with conventional WBRT, did not translate to a mean improvement in QoL. There was no symptomatic intracranial progression of disease while the patients remained on study. Two patients had MRI at 3 months, and both had evidence of intracranial progression of disease within the volume that had received prescription WBRT dose. From the data collected it seems that VMAT hair-sparing WBRT was well-tolerated. Conclusion: VMAT hair-sparing WBRT partially spared scalp hair at four weeks post WBRT and did not compromise symptomatic disease control during the study. The treating oncologists observed that the hair grew back quicker than with conventional WBRT, and that combined cytotoxic chemotherapy was additive to RT-induced alopecia. However, the study was not optimal in that data collection was hampered by patient availability. The patient population was too unwell to be followed up according to the protocol.
全脑放疗(WBRT)是一种常见的治疗实体瘤脑转移的姑息性治疗方法。传统上,当有头发的头皮皮肤接受全剂量时,它与相反的外侧野一起给予,导致完全脱发。体积调节电弧疗法(VMAT)可以在对较大转移灶同时进行综合增强(SIB)的同时,将对关键结构(如海马)的剂量降至最低。本可行性研究旨在验证以下假设:使用VMAT保发WBRT方案减少头皮剂量,可在治疗后四周保留头皮毛发并减少脱发,而不影响治疗后三个月的疾病控制。方法:毛发稀疏研究(01.07 WBRTMel子研究SS01.13)是一项由研究者发起的前瞻性可行性研究。制定了VMAT保发WBRT方案,将对头皮的剂量限制在15个分数的16格雷(Gy)。主要目的是通过CTCAE v4和临床医生和患者的感知来测量RT后4周的脱发率。生活质量(QoL)在基线、治疗后1个月和3个月进行评估,使用经过验证的工具,包括欧洲癌症研究和治疗组织(EORTC)生活质量问卷(QLQ-C15-PAL+4)以及与头发有关的四个附加问题,视觉模拟量表(VAS)测量脱发严重程度的感知,以及总化疗引起的脱发困扰量表(CADS)。结果:9例黑色素瘤(6例)、乳腺癌(2例)和肺癌(1例)脑转移患者入组于澳大利亚乌鸦巢的Mater Sydney医院。4周时,5例患者可评估:4例报告中度脱发(CTCAE v4 2级),1例报告轻度脱发(CTCAE v4 1级)。5例患者均佩戴假发或围巾以掩盖脱发。任何程度的脱发都会影响生活质量。与完全脱发相比,通常在常规WBRT中发现的脱发减少并没有转化为生活质量的平均改善。在患者继续研究期间,没有出现症状性颅内疾病进展。两名患者在3个月时进行了MRI检查,均有证据表明,在接受处方WBRT剂量的体积内,疾病发生了颅内进展。从收集的数据来看,VMAT保发WBRT似乎耐受性良好。结论:VMAT保发WBRT在WBRT后4周部分保留了头皮毛发,并且在研究期间不影响症状性疾病控制。治疗肿瘤学家观察到,与传统的WBRT相比,头发长得更快,并且联合细胞毒性化疗对rt诱导的脱发有附加作用。然而,该研究并不是最佳的,因为数据收集受到患者可用性的阻碍。患者群体过于不适,无法按照协议进行随访。
{"title":"Whole brain radiotherapy with partial hair-sparing technique-a feasibility study","authors":"Narelle Williams, F. Boyle, A. Hong, Hsien Chan, E. Paton, Kerryn Miller, Z. Moutrie, Sinead Mulrennan, Bianca Karle, Gerald B Fobarty","doi":"10.15406/ijrrt.2020.07.00274","DOIUrl":"https://doi.org/10.15406/ijrrt.2020.07.00274","url":null,"abstract":"Introduction: Whole brain radiotherapy (WBRT) is a common palliative treatment for brain metastases from solid tumours. Traditionally, it is given with opposed lateral fields causing total alopecia as hair-bearing scalp skin receives the full dose. Volumetric modulated arc therapy (VMAT) can deliver WBRT with a simultaneous integrated boost (SIB) to larger metastases whilst minimising dose to critical structures such as the hippocampus. This feasibility study aimed to test the hypothesis that a reduced dose to the scalp using a VMAT hair-sparing WBRT protocol would spare scalp hair and reduce alopecia at four weeks post treatment without compromising disease control at three months. Methods: The Hair Spare study (01.07 WBRTMel sub-study SS01.13) was an investigator-initiated, prospective feasibility study. A VMAT hair-sparing WBRT protocol was developed to limit the dose to the scalp to 16 Gray (Gy) in 15 fractions. The primary objective was the rate of alopecia at 4 weeks post RT as measured by CTCAE v4 and clinician and patient perception. Quality of life (QoL) was assessed at baseline, one month and three months post treatment with validated instruments including European Organisation for Research and Treatment of Cancer (EORTC) QoL Questionnaire (QLQ-C15-PAL+4) plus four additional questions specifically relating to hair, a visual analogue scale (VAS) to measure the perception of hair loss severity, and the total Chemotherapy-Induced Alopecia Distress Scale (CADS). Results: Nine patients with brain metastases from melanoma (6), breast (2) and lung (1) cancer were enrolled at the Mater Sydney Hospital, Crows Nest, Australia. At 4 weeks, 5 patients were evaluable: 4 reported moderate alopecia (CTCAE v4 Grade 2) and 1 reported mild alopecia (CTCAE v4 Grade 1). All 5 wore wigs or scarves to hide hair loss. Any amount of hair loss impacted QoL. Reduced hair loss compared to complete alopecia, as usually found with conventional WBRT, did not translate to a mean improvement in QoL. There was no symptomatic intracranial progression of disease while the patients remained on study. Two patients had MRI at 3 months, and both had evidence of intracranial progression of disease within the volume that had received prescription WBRT dose. From the data collected it seems that VMAT hair-sparing WBRT was well-tolerated. Conclusion: VMAT hair-sparing WBRT partially spared scalp hair at four weeks post WBRT and did not compromise symptomatic disease control during the study. The treating oncologists observed that the hair grew back quicker than with conventional WBRT, and that combined cytotoxic chemotherapy was additive to RT-induced alopecia. However, the study was not optimal in that data collection was hampered by patient availability. The patient population was too unwell to be followed up according to the protocol.","PeriodicalId":214028,"journal":{"name":"International Journal of Radiology & Radiation Therapy","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123362095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Activity of the chloroquine/hydroxychloroquine and mefloquine in front of the SARS-CoV-2 氯喹/羟氯喹和甲氟喹在SARS-CoV-2前的活性
Pub Date : 2020-07-14 DOI: 10.23880/ijnmrs-16000130
Elin Manrique Julio, Belkis Palacio Villalba, Elías Alberto Bedoya Marrugo, M. D. Lengua
Introduction: Identifying the main advances in the pharmacological and clinical management of the pandemic COVID-19 and SARS-CoV-2, the most recent and currently taking lives worldwide, is to priority of the scientific community that to date have rehearsed and joined efforts in order to respond with effective treatments that stop the progression of the viral infection and manage to recover the patient. Objective: To document available information on the effects of the antimalarials chloroquine / hydroxychloroquine and mefloquine in severe acute respiratory syndrome, generated by SARS CoV-2, according to updates of the best scientific evidence, according to the evolution of the epidemic. Material and Methods: Descriptive documentary study consisting of the selection and review of scientific material whose subject is COVID-19 and SARS-CoV-2 based on published evidence from bibliographic sources seeking different therapeutic options to combat the disease at the same time ace necessary preventive measures plough implemented worldwide. The databases consulted were Scopus, Head office Pubmed and Scielo. Results: 132 articles related to the search were obtained in the first instance, of which they were filtered and prioritized by thematic relevance until 60 articles with to broad relationship were located. The largest number of articles was published between 2015 and 2020 (n = 26; 43.3%). It have been shown that the mechanism of today's SARS-CoV-2 is similar to that of SARS-CoV and MERS-CoV, in the same way; they share the symptoms shown by patients with COVID-19 such ace: fever, non-productive cough, dyspnea, myalgia, fatigue, normal or decreased white blood cell counts. Conclusions: The activity of hydroxychloroquine and chloroquine in viruses is the same since the mechanism of action of these two molecules is identical. Given the pandemic, the use of these drugs is suggested in the management of patients with SARS CoV-2 / COVID-19 infection that have no contraindication for their use and the cardiac toxicity derived from these ace to cause of mortality should not be forgotten, due to what therapy must be individualized. The mefloquine is not recommended due to its neurotoxic effect and association with neuropsychiatric adverse reactions.
导论:确定大流行COVID-19和SARS-CoV-2的药理学和临床管理方面的主要进展是科学界的优先事项,迄今为止,科学界已经进行了预演和共同努力,以便采取有效的治疗措施,阻止病毒感染的进展并设法使患者康复。目的:根据最新的最佳科学证据,根据疫情的演变,记录有关抗疟药物氯喹/羟氯喹和甲氟喹对SARS - CoV-2引起的严重急性呼吸系统综合征的影响的现有信息。材料和方法:描述性文献研究,包括根据文献来源的已发表证据,选择和审查以COVID-19和SARS-CoV-2为主题的科学材料,寻求不同的治疗方案,同时在全球范围内实施必要的预防措施。参考的数据库有Scopus、Pubmed总部和Scielo。结果:第一次获得与搜索相关的132篇文章,对其进行主题相关性过滤和优先级排序,直到找到60篇具有广泛关系的文章。2015 - 2020年间发表的文章最多(n = 26;43.3%)。研究表明,今天的SARS-CoV-2的机制与SARS-CoV和MERS-CoV的机制相似,方式相同;他们都有COVID-19患者所表现出的症状,如发烧、无产出性咳嗽、呼吸困难、肌痛、疲劳、白细胞计数正常或减少。结论:羟氯喹和氯喹在病毒中的活性是相同的,因为这两种分子的作用机制相同。鉴于大流行,建议在无禁忌症的SARS - CoV-2 / COVID-19感染患者的管理中使用这些药物,并且由于必须个体化治疗,因此不应忘记这些药物引起的心脏毒性是导致死亡的原因。甲氟喹由于其神经毒性作用和与神经精神不良反应相关而不推荐使用。
{"title":"Activity of the chloroquine/hydroxychloroquine and mefloquine in front of the SARS-CoV-2","authors":"Elin Manrique Julio, Belkis Palacio Villalba, Elías Alberto Bedoya Marrugo, M. D. Lengua","doi":"10.23880/ijnmrs-16000130","DOIUrl":"https://doi.org/10.23880/ijnmrs-16000130","url":null,"abstract":"Introduction: Identifying the main advances in the pharmacological and clinical management of the pandemic COVID-19 and SARS-CoV-2, the most recent and currently taking lives worldwide, is to priority of the scientific community that to date have rehearsed and joined efforts in order to respond with effective treatments that stop the progression of the viral infection and manage to recover the patient. Objective: To document available information on the effects of the antimalarials chloroquine / hydroxychloroquine and mefloquine in severe acute respiratory syndrome, generated by SARS CoV-2, according to updates of the best scientific evidence, according to the evolution of the epidemic. Material and Methods: Descriptive documentary study consisting of the selection and review of scientific material whose subject is COVID-19 and SARS-CoV-2 based on published evidence from bibliographic sources seeking different therapeutic options to combat the disease at the same time ace necessary preventive measures plough implemented worldwide. The databases consulted were Scopus, Head office Pubmed and Scielo. Results: 132 articles related to the search were obtained in the first instance, of which they were filtered and prioritized by thematic relevance until 60 articles with to broad relationship were located. The largest number of articles was published between 2015 and 2020 (n = 26; 43.3%). It have been shown that the mechanism of today's SARS-CoV-2 is similar to that of SARS-CoV and MERS-CoV, in the same way; they share the symptoms shown by patients with COVID-19 such ace: fever, non-productive cough, dyspnea, myalgia, fatigue, normal or decreased white blood cell counts. Conclusions: The activity of hydroxychloroquine and chloroquine in viruses is the same since the mechanism of action of these two molecules is identical. Given the pandemic, the use of these drugs is suggested in the management of patients with SARS CoV-2 / COVID-19 infection that have no contraindication for their use and the cardiac toxicity derived from these ace to cause of mortality should not be forgotten, due to what therapy must be individualized. The mefloquine is not recommended due to its neurotoxic effect and association with neuropsychiatric adverse reactions.","PeriodicalId":214028,"journal":{"name":"International Journal of Radiology & Radiation Therapy","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123141141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
https://medcraveonline.com/IJRRT/volume_issues?issueId=3167&volumeId=782 https://medcraveonline.com/IJRRT/volume_issues?issueId=3167&volumeId=782
Pub Date : 2020-07-10 DOI: 10.15406/ijrrt.2020.07.00272
Berdichevskyy Ba, Berdichevskyy Vb
{"title":"https://medcraveonline.com/IJRRT/volume_issues?issueId=3167&volumeId=782","authors":"Berdichevskyy Ba, Berdichevskyy Vb","doi":"10.15406/ijrrt.2020.07.00272","DOIUrl":"https://doi.org/10.15406/ijrrt.2020.07.00272","url":null,"abstract":"","PeriodicalId":214028,"journal":{"name":"International Journal of Radiology & Radiation Therapy","volume":"283 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115337991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Volumetric modulated arc therapy (VMAT) provides the conformality that enables three separate simultaneous pelvic malignancies to be treated radically–a case study 容积调节弧线疗法(VMAT)提供了合规性,使三个独立的盆腔恶性肿瘤同时得到彻底治疗
Pub Date : 2020-07-03 DOI: 10.15406/ijrrt.2020.07.00271
Callista V Raharjo, Colin Chen, F. Lam, S. O'Neill, J. Almeida, J. Turner, Robyn Levingston, Anna O’ Keefe, I. Quin, G. Fogarty
Radiotherapy and surgery are both potential modalities for the definitive treatment of pelvic malignancies. Although surgery provides a histological specimen, enabling exact staging, radiotherapy is sometimes preferred as it provides patients the opportunity for organ conservation and therefore perhaps better quality post-treatment survivorship. Our case report details how three separate primary pelvic cancers (prostate, rectal, anal) in one patient were treated simultaneously with definitive radiotherapy. Patient was prescribed 80 Gy in 40 fractions to the planning target volume (PTV) prostate, 54 Gy to PTV anal canal, 45 Gy to the pelvis including PTV rectosigmoid junction and 36 Gy to the PTV inguinal lymph nodes that encompassed clinically negative nodes draining the anus, through the Volumetric Modulated Arc Therapy (VMAT) with 6MV photons. Mean doses to organs at risk (OAR) are 30.01 Gy to the bowel volume, 46.54 Gy to the bladder, 30.42 Gy to the femurs, and 61.84 Gy to the rectum. Radiation doses to the prostate and anal canal are consistent with conventional treatment doses with definitive radiotherapy. The rectal dose was accepted as part of the definitive treatment of rectal cancer following Endoscopic Mucosal Resection (EMR). This could only be achieved through the superior dose conformality of VMAT, maximising the dose given to tumour bearing PTV while minimising the dose to OARs which included normal pelvic structures. All three cancers remained under control at 4 years after treatment, with minimal late toxicity associated with the treatment received. Further RCTs in pelvic malignancies are needed to help clinicians and patients select the best treatments, to improve disease control while maintaining quality of survivorship.
放疗和手术都是盆腔恶性肿瘤最终治疗的潜在方式。虽然手术提供了组织学标本,可以精确分期,但放疗有时更可取,因为它为患者提供了器官保存的机会,因此可能有更好的治疗后生存质量。我们的病例报告详细介绍了一位患者的三种不同的原发性盆腔癌(前列腺癌、直肠癌、肛门癌)如何同时接受明确的放射治疗。通过6MV光子的体积调制弧线治疗(VMAT),患者在计划靶体积(PTV)前列腺上给予80 Gy,在PTV肛管上给予54 Gy,在骨盆上给予45 Gy,包括PTV直肠乙状结肠结,在PTV腹股沟淋巴结上给予36 Gy, PTV腹股沟淋巴结包括临床阴性淋巴结引流肛门。对危险器官(OAR)的平均剂量对肠容量为30.01 Gy,对膀胱为46.54 Gy,对股骨为30.42 Gy,对直肠为61.84 Gy。前列腺和肛管的放射剂量与常规放射治疗剂量一致。直肠剂量被接受为内镜下粘膜切除(EMR)后直肠癌最终治疗的一部分。这只能通过VMAT的高剂量一致性来实现,即对带肿瘤的PTV给予最大剂量,而对包括正常骨盆结构的OARs给予最小剂量。所有三种癌症在治疗后4年仍得到控制,与所接受治疗相关的晚期毒性最小。需要进一步的盆腔恶性肿瘤随机对照试验来帮助临床医生和患者选择最佳治疗方法,在保持生存质量的同时改善疾病控制。
{"title":"Volumetric modulated arc therapy (VMAT) provides the conformality that enables three separate simultaneous pelvic malignancies to be treated radically–a case study","authors":"Callista V Raharjo, Colin Chen, F. Lam, S. O'Neill, J. Almeida, J. Turner, Robyn Levingston, Anna O’ Keefe, I. Quin, G. Fogarty","doi":"10.15406/ijrrt.2020.07.00271","DOIUrl":"https://doi.org/10.15406/ijrrt.2020.07.00271","url":null,"abstract":"Radiotherapy and surgery are both potential modalities for the definitive treatment of pelvic malignancies. Although surgery provides a histological specimen, enabling exact staging, radiotherapy is sometimes preferred as it provides patients the opportunity for organ conservation and therefore perhaps better quality post-treatment survivorship. Our case report details how three separate primary pelvic cancers (prostate, rectal, anal) in one patient were treated simultaneously with definitive radiotherapy. Patient was prescribed 80 Gy in 40 fractions to the planning target volume (PTV) prostate, 54 Gy to PTV anal canal, 45 Gy to the pelvis including PTV rectosigmoid junction and 36 Gy to the PTV inguinal lymph nodes that encompassed clinically negative nodes draining the anus, through the Volumetric Modulated Arc Therapy (VMAT) with 6MV photons. Mean doses to organs at risk (OAR) are 30.01 Gy to the bowel volume, 46.54 Gy to the bladder, 30.42 Gy to the femurs, and 61.84 Gy to the rectum. Radiation doses to the prostate and anal canal are consistent with conventional treatment doses with definitive radiotherapy. The rectal dose was accepted as part of the definitive treatment of rectal cancer following Endoscopic Mucosal Resection (EMR). This could only be achieved through the superior dose conformality of VMAT, maximising the dose given to tumour bearing PTV while minimising the dose to OARs which included normal pelvic structures. All three cancers remained under control at 4 years after treatment, with minimal late toxicity associated with the treatment received. Further RCTs in pelvic malignancies are needed to help clinicians and patients select the best treatments, to improve disease control while maintaining quality of survivorship.","PeriodicalId":214028,"journal":{"name":"International Journal of Radiology & Radiation Therapy","volume":"65 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131668591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inguinoscrotal bladder hernia: incidental finding on bone scintigraphy 腹股沟阴囊膀胱疝:骨显像偶然发现
Pub Date : 2020-06-20 DOI: 10.15406/IJRRT.2020.07.00269
A. Cardozo-Saavedra, D. Villasboas-Rosciolesi, E. Carrillo-Villamizar, Sandra Menéndez-Sánchez, R. Bellviure-Meiro, A. García-Burillo, J. Castell‐Conesa
Inguinoscrotal hernia of the bladder is relatively uncommon, difficult to diagnose and remain a surgical challenge.[1,2,3,4] We report a 72-years-old man with a recent diagnosis of prostate neoplasm who underwent a Technetium-99 hidroximethylene-diphosphonate (Tc-99m HMDP) bone scintigraphy which reveals, as an incidental finding, a left inguinoscrotal hernia containing a portion of the urinary bladder.
腹股沟阴囊疝的膀胱是相对罕见的,难以诊断和仍然是一个外科挑战。[1,2,3,4]我们报告一位最近诊断为前列腺肿瘤的72岁男性患者,他接受了锝-99氢氧亚甲基二膦酸盐(Tc-99m HMDP)骨显像检查,作为偶然发现,左侧腹股沟阴囊疝包含部分膀胱。
{"title":"Inguinoscrotal bladder hernia: incidental finding on bone scintigraphy","authors":"A. Cardozo-Saavedra, D. Villasboas-Rosciolesi, E. Carrillo-Villamizar, Sandra Menéndez-Sánchez, R. Bellviure-Meiro, A. García-Burillo, J. Castell‐Conesa","doi":"10.15406/IJRRT.2020.07.00269","DOIUrl":"https://doi.org/10.15406/IJRRT.2020.07.00269","url":null,"abstract":"Inguinoscrotal hernia of the bladder is relatively uncommon, difficult to diagnose and remain a surgical challenge.[1,2,3,4] We report a 72-years-old man with a recent diagnosis of prostate neoplasm who underwent a Technetium-99 hidroximethylene-diphosphonate (Tc-99m HMDP) bone scintigraphy which reveals, as an incidental finding, a left inguinoscrotal hernia containing a portion of the urinary bladder.","PeriodicalId":214028,"journal":{"name":"International Journal of Radiology & Radiation Therapy","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126657866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experiences when irradiating grafts and flaps for skin cancer 照射皮肤癌移植物和皮瓣的经验
Pub Date : 2020-05-25 DOI: 10.15406/IJRRT.2020.07.00268
L. Dwyer, Roger L Haddad, G. Fogarty
"Resection of skin cancer with graft or flap repair may be referred for local postoperative radiotherapy (PORT) to ensure local control." PORT needs to be delivered in a certain time frame after surgery, but this may impact on graft and flap survival. The purpose of this article is to pass on some experience our multidisciplinary team has acquired in order to assist in the management of these cases. Specifically, pertinent issues in patient assessment (history and examination), indications for PORT, the differences between a graft and a flap, and technical considerations in the prescription of radiotherapy to these are covered, accompanied by illustrative cases with appropriate photographs and diagrams. The principal findings are that a conservative approach may need to be taken to ensure graft and flap survival, with PORT reserved for a role in salvage. Other interesting cases cover the lack of acute radiation side effects in flaps; the tendency of acute radiation skin toxicity to move with gravity, and transplanted skin may have a different radiation sensitivity to that of its new environment. We hope that this article will be of use for the multidisciplinary skin oncology team. Further research is needed to validate and confirm our findings.
“皮肤肿瘤切除与移植或皮瓣修复可参考局部术后放疗(PORT),以确保局部控制。”PORT需要在术后一定时间内进行,但这可能会影响移植物和皮瓣的存活。本文的目的是传递我们多学科团队获得的一些经验,以协助管理这些病例。具体而言,包括患者评估(病史和检查)的相关问题,PORT的适应症,移植物和皮瓣之间的差异,以及放射治疗处方中的技术考虑,并附有适当的照片和图表的说明性病例。本研究的主要发现是,可能需要采取保守的方法来确保移植物和皮瓣的存活,PORT保留在抢救中的作用。其他有趣的例子包括皮瓣没有急性辐射副作用;急性辐射皮肤毒性随重力移动的趋势,移植皮肤对新环境的辐射敏感性可能不同。我们希望这篇文章能对多学科皮肤肿瘤学团队有所帮助。需要进一步的研究来验证和确认我们的发现。
{"title":"Experiences when irradiating grafts and flaps for skin cancer","authors":"L. Dwyer, Roger L Haddad, G. Fogarty","doi":"10.15406/IJRRT.2020.07.00268","DOIUrl":"https://doi.org/10.15406/IJRRT.2020.07.00268","url":null,"abstract":"\"Resection of skin cancer with graft or flap repair may be referred for local postoperative radiotherapy (PORT) to ensure local control.\" PORT needs to be delivered in a certain time frame after surgery, but this may impact on graft and flap survival. The purpose of this article is to pass on some experience our multidisciplinary team has acquired in order to assist in the management of these cases. Specifically, pertinent issues in patient assessment (history and examination), indications for PORT, the differences between a graft and a flap, and technical considerations in the prescription of radiotherapy to these are covered, accompanied by illustrative cases with appropriate photographs and diagrams. The principal findings are that a conservative approach may need to be taken to ensure graft and flap survival, with PORT reserved for a role in salvage. Other interesting cases cover the lack of acute radiation side effects in flaps; the tendency of acute radiation skin toxicity to move with gravity, and transplanted skin may have a different radiation sensitivity to that of its new environment. We hope that this article will be of use for the multidisciplinary skin oncology team. Further research is needed to validate and confirm our findings.","PeriodicalId":214028,"journal":{"name":"International Journal of Radiology & Radiation Therapy","volume":"73 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127136402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Less is more when treating the nasal ala with superficial radiotherapy 浅表放射治疗鼻翼时,少即是多
Pub Date : 2020-05-20 DOI: 10.15406/IJRRT.2020.07.00267
L. Butcher, G. Fogarty, S. Sinclair, Hanna Kuchel, R. Paver
Skin cancer is the most common malignancy, is increasing in incidence, and occurs most commonly on the head and neck. Cancers of the nasal ala pose therapeutic challenges given the cosmetic and functional importance. Both surgery and radiotherapy (RT) have similar oncological outcomes. RT is tissue-conserving and may have an advantage in cosmetic and functional outcomes, but more comparative trials are needed. RT needs to be delivered well to avoid late effects such as skin atrophy, fibrosis and telangiectasia, which may increase with higher dose per fraction. We describe three cases of self-reported thinning of the nasal ala following definitive mildly hypofractionated superficial radiotherapy (SXRT) of 2.5 Gy per fraction. SXRT to skin cancers of the nasal alar with standard fractionation of at most 2 Gy per fraction may be important in ensuring excellent cosmetic outcomes and patient satisfaction.
皮肤癌是最常见的恶性肿瘤,发病率正在增加,最常见于头部和颈部。癌症的鼻翼提出了治疗挑战鉴于美容和功能的重要性。手术和放疗(RT)具有相似的肿瘤预后。放疗是组织保存,可能在美容和功能结果上有优势,但需要更多的比较试验。RT需要很好地传递,以避免后期效应,如皮肤萎缩,纤维化和毛细血管扩张,这可能随着剂量的增加而增加。我们描述了三例自我报告的鼻翼变薄后,明确轻度低分割浅表放疗(SXRT) 2.5 Gy每分数。鼻鼻翼皮肤癌的SXRT标准分数最多为每分数2 Gy,对于确保良好的美容效果和患者满意度可能是重要的。
{"title":"Less is more when treating the nasal ala with superficial radiotherapy","authors":"L. Butcher, G. Fogarty, S. Sinclair, Hanna Kuchel, R. Paver","doi":"10.15406/IJRRT.2020.07.00267","DOIUrl":"https://doi.org/10.15406/IJRRT.2020.07.00267","url":null,"abstract":"Skin cancer is the most common malignancy, is increasing in incidence, and occurs most commonly on the head and neck. Cancers of the nasal ala pose therapeutic challenges given the cosmetic and functional importance. Both surgery and radiotherapy (RT) have similar oncological outcomes. RT is tissue-conserving and may have an advantage in cosmetic and functional outcomes, but more comparative trials are needed. RT needs to be delivered well to avoid late effects such as skin atrophy, fibrosis and telangiectasia, which may increase with higher dose per fraction. We describe three cases of self-reported thinning of the nasal ala following definitive mildly hypofractionated superficial radiotherapy (SXRT) of 2.5 Gy per fraction. SXRT to skin cancers of the nasal alar with standard fractionation of at most 2 Gy per fraction may be important in ensuring excellent cosmetic outcomes and patient satisfaction.","PeriodicalId":214028,"journal":{"name":"International Journal of Radiology & Radiation Therapy","volume":"101 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133819173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emotional and disability status in patients with chronic low back pain 慢性腰痛患者的情绪和残疾状况
Pub Date : 2020-04-30 DOI: 10.15406/IJRRT.2020.07.00265
Mayra Campos Frâncica dos Santos, J. P. M. Santos, Rubens Alexandre da Silva Junior, R. A. P. Ferrari, L. M. Iida, R. Andraus, Sue Ellen Ferreira Modesto Rey de Figueiredo, K. Fernandes
Objective: to analyze the prevalence of psychological disorders (anxiety, depression, stress) and the relationship of these factors with functional disability in patients with chronic low back pain. Study design: cross-sectional descriptive and observational study. Setting: the physiotherapy outpatient clinic of the Northen University of Paraná, Londrina, Paraná, Brazil. Methods: 84 individuals were recruited, being 43 elderly (20 with low back pain and 23 control subjects) and 41 adults (21 with low back pain and 20 control subjects). In order to assess the psychological aspects, Beck Inventories of Depression and anxiety as well as Lipp Stress Inventory were used. To evaluate the funcionality, Roland Morris Questionnaire was chosen. The evaluation of the pressure pain threshold was performed using algometer emg systems®. To analyse was considered a significance level of 5% (p<0.05). Results: It was observed that people with low back pain have higher scores of depression, anxiety, stress and functional disability compared to the control group (p<0.05). Among adults, an inverse relationship between anxiety and disability (p<0.05) was observed. In subjects with low back pain positive correlation was observed between anxiety and functional disability and, between the depression and functional disability (p<0.05). In addition, no association was found between stress and functional disability in patients with low back pain (p<0.05). Conclusion: suggest that in patients with low back pain worsening of functionality is anxiety and stress and elderly people with low back pain has higher levels of stress, depression, anxiety and function disability.
目的:分析慢性腰痛患者心理障碍(焦虑、抑郁、应激)的患病率及其与功能障碍的关系。研究设计:横断面描述性和观察性研究。地点:巴西帕拉纳隆德里纳北部帕拉纳大学物理治疗门诊。方法:共招募84人,其中老年人43人(腰痛患者20人,对照组23人),成人41人(腰痛患者21人,对照组20人)。为了评估心理方面,使用贝克抑郁和焦虑量表以及利普压力量表。为了评估其功能,我们选择了罗兰莫里斯问卷。使用algometer emg系统®对压力痛阈值进行评估。分析认为显著性水平为5% (p<0.05)。结果:腰痛组抑郁、焦虑、压力、功能障碍得分均高于对照组(p<0.05)。在成人中,焦虑与残疾呈负相关(p<0.05)。腰痛患者焦虑与功能障碍呈正相关,抑郁与功能障碍呈正相关(p<0.05)。此外,腰痛患者的压力与功能障碍之间没有相关性(p<0.05)。结论:提示腰痛患者的功能恶化表现为焦虑和应激,老年腰痛患者的应激、抑郁、焦虑和功能障碍水平较高。
{"title":"Emotional and disability status in patients with chronic low back pain","authors":"Mayra Campos Frâncica dos Santos, J. P. M. Santos, Rubens Alexandre da Silva Junior, R. A. P. Ferrari, L. M. Iida, R. Andraus, Sue Ellen Ferreira Modesto Rey de Figueiredo, K. Fernandes","doi":"10.15406/IJRRT.2020.07.00265","DOIUrl":"https://doi.org/10.15406/IJRRT.2020.07.00265","url":null,"abstract":"Objective: to analyze the prevalence of psychological disorders (anxiety, depression, stress) and the relationship of these factors with functional disability in patients with chronic low back pain. Study design: cross-sectional descriptive and observational study. Setting: the physiotherapy outpatient clinic of the Northen University of Paraná, Londrina, Paraná, Brazil. Methods: 84 individuals were recruited, being 43 elderly (20 with low back pain and 23 control subjects) and 41 adults (21 with low back pain and 20 control subjects). In order to assess the psychological aspects, Beck Inventories of Depression and anxiety as well as Lipp Stress Inventory were used. To evaluate the funcionality, Roland Morris Questionnaire was chosen. The evaluation of the pressure pain threshold was performed using algometer emg systems®. To analyse was considered a significance level of 5% (p<0.05). Results: It was observed that people with low back pain have higher scores of depression, anxiety, stress and functional disability compared to the control group (p<0.05). Among adults, an inverse relationship between anxiety and disability (p<0.05) was observed. In subjects with low back pain positive correlation was observed between anxiety and functional disability and, between the depression and functional disability (p<0.05). In addition, no association was found between stress and functional disability in patients with low back pain (p<0.05). Conclusion: suggest that in patients with low back pain worsening of functionality is anxiety and stress and elderly people with low back pain has higher levels of stress, depression, anxiety and function disability.","PeriodicalId":214028,"journal":{"name":"International Journal of Radiology & Radiation Therapy","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124880736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Radiology & Radiation Therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1